Cowen And Company, LLC Sc Pharmaceuticals Inc. Transaction History

Cowen And Company, LLC

  • $3.88 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 09, 2023
SELL
$7.0 - $9.82 $295,897 - $415,101
-42,271 Reduced 2.3%
1,795,647 $12.8 Million
Q2 2023

Aug 07, 2023
SELL
$8.94 - $11.74 $8.67 Million - $11.4 Million
-969,644 Reduced 34.54%
1,837,918 $18.7 Million
Q1 2023

May 09, 2023
BUY
$5.59 - $9.47 $15.7 Million - $26.6 Million
2,807,562 New
2,807,562 $25.5 Million

Others Institutions Holding SCPH

# of Institutions
96
Shares Held
37.1M
Call Options Held
110K
Put Options Held
12.1K
View Full List

About scPharmaceuticals Inc.

SCPH Quotes by TradingView
  • Ticker SCPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 27,402,100
  • Market Cap $92.9M
  • Description
  • scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product p...
More about SCPH
Track This Portfolio

Track Cowen And Company, LLC Portfolio

Follow Cowen And Company, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cowen And Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cowen And Company, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email